$SNEX

Smith Philip Andrew sold $3.3M of SNEX

Smith Philip Andrew (Chief Executive Officer) sold 45,000 shares of StoneX Group Inc. (SNEX) at $74.32 ($3.34M total) on 2026-07-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Philip Andrew
Published Jul 24, 2026, 12:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
high confidence
Mentioned
$SNEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The disclosure provides transparency on insider selling activity but does not introduce new company performance, strategy, or risk information.

02

Market read

Insider selling can be a minor sentiment input, but 10b5-1 context usually limits interpretive value.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or risk events, the signal is typically weak.

Relevance 5/10Novelty 3/10Timing: new Form 4 filed 2026-07-23 for a 2026-07-22 sale

Background

The article is a SEC Form 4 insider transaction disclosure for StoneX Group CEO Philip Andrew Smith.

Company-level read

Ticker impact

$SNEXNeutralHigh confidence
Context

CEO Philip Andrew Smith sold 45,000 shares of StoneX Group at $74.3218 on 2026-07-22 under a 10b5-1 plan, per Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.

Evidence & confidence

The filing is a routine Form 4 transaction with a stated pre-arranged 10b5-1 plan, and it does not include new guidance, financial results, or operational/regulatory developments.

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • StoneX Group Inc.

    Subject of the Form 4 insider transaction disclosure (SNEX).

  • Philip Andrew Smith

    CEO and director who sold 45,000 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.